GSK plc (GLAXF) stock
GLAXFOTCPharmaceutical PreparationsAlso trades as GSK
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$24.74+0.30 (+1.21%)
Close on Oct 19, 2026Market cap $106.83BP/E 13.3Yield –
GSK profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2025 it was 17.5%, against 8.2% the year before. The highest annual figure on record is 51.0% in fiscal 2022.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17.5% | +9.3 |
| FY2024 | Dec 31, 2024 | 8.2% | −8.0 |
| FY2023 | Dec 31, 2023 | 16.2% | −34.8 |
| FY2022 | Dec 31, 2022 | 51.0% | +33.2 |
| FY2021 | Dec 31, 2021 | 17.8% | −5.9 |
| FY2020 | Dec 31, 2020 | 23.6% | +9.8 |
| FY2019 | Dec 31, 2019 | 13.8% | +2.0 |
| FY2018 | Dec 31, 2018 | 11.8% | +6.7 |
| FY2017 | Dec 31, 2017 | 5.1% | +1.8 |
| FY2016 | Dec 31, 2016 | 3.3% | −31.9 |
| FY2015 | Dec 31, 2015 | 35.2% | – |